Literature DB >> 21316959

Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids.

Marli C Lombard1, David D N'Da, Jaco C Breytenbach, Peter J Smith, Carmen A Lategan.   

Abstract

Dihydroartemisinin (DHA) was coupled to different aminoquinoline moieties forming hybrids 9-14, which were then treated with oxalic acid to form oxalate salts (9a-14a). Compounds 9a, 10a, 12, 12a, and 14a showed comparable potency in vitro to that of chloroquine (CQ) against the chloroquine sensitive (CQS) strain, and were found to be more potent against the chloroquine resistant CQR strain. Hybrids 12 and its oxalate salt 12a were the most active against CQR strain, being 9- and 7-fold more active than CQ, respectively (17.12 nM; 20.76 nM vs 157.9 nM). An optimum chain length was identified having 2 or 3 Cs with or without an extra methylene substituent.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316959     DOI: 10.1016/j.bmcl.2011.01.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Synthesis, Structure-Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines.

Authors:  Guang Huang; Claribel Murillo Solano; Joel Melendez; Justin Shaw; Jennifer Collins; Robert Banks; Arash Keshavarzi Arshadi; Rachasak Boonhok; Hui Min; Jun Miao; Debopam Chakrabarti; Yu Yuan
Journal:  J Med Chem       Date:  2020-10-06       Impact factor: 7.446

2.  Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids.

Authors:  Marli C Lombard; David D N'Da; Christophe Tran Van Ba; Sharon Wein; Jennifer Norman; Lubbe Wiesner; Henri Vial
Journal:  Malar J       Date:  2013-02-21       Impact factor: 2.979

Review 3.  Quinoline-Based Hybrid Compounds with Antimalarial Activity.

Authors:  Xhamla Nqoro; Naki Tobeka; Blessing A Aderibigbe
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

Review 4.  Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.

Authors:  Sijongesonke Peter; Siphesihle Jama; Sibusiso Alven; Blessing A Aderibigbe
Journal:  Molecules       Date:  2021-12-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.